| |
| |
|
| |
|
|
| |
| |
| |
Barry R. Bochner, Ph.D., Chairman and President |
| |
| |
| Barry co-founded Biolog and currently serves as President and Chairman of the Board of Directors. He has led the R&D efforts at Biolog since its inception, resulting in numerous issued or allowed U.S. and international patents. Prior to Biolog, he was a senior scientist and group leader at Genentech, Inc., working on production of recombinant proteins in microorganisms. Barry earned an S.B. in Biology and an S.M. from the Massachusetts Institute of Technology, a Ph.D. in Bioengineering from the University of Michigan, and was a Senior Postdoctoral Fellow in Biochemistry with Bruce N. Ames, Ph.D., at the University of California, Berkeley. |
|
| |
| |
| |
| |
 |
| |
| |
| |
Donald W. Barnby, S.M., M.B.A., Director |
| |
| |
| Don co-founded Biolog and
served as the Company's President and CEO, CFO and Corporate
Secretary through 1999. Don began his career with Owens-Illinois,
Inc. as an Industrial Engineer, and left to join Sinclair
Koppers Company where he was promoted to Plant Manager.
In 1971 and 1972, Don served as Deputy Chief of the Control
Division, Pay Board, in the Executive Office of the President
of the United States. From 1977 to 1980, he was a consultant
to new venture start-ups and served as President of Innovative
Design Company. He also served as an officer in the U.S.
Army Signal Corps. Don received an S.B. in Chemical Engineering
and an S.M. in Chemical Engineering Practice from the
Massachusetts Institute of Technology, and an M.B.A. in
Finance and Marketing from the Stanford University Graduate
School of Business. |
|
 |
| |
|
| |
| |
| |
Dennis. W. Harris, Ph.D., Director |
| |
| |
| Dennis has held high positions in science and management in some of the most innovative and successful biotech companies. He obtained a Ph.D. in Biochemistry in 1981 from the University of Sussex and began his career working for 13 years at Amersham International in the UK, rising to the position of Research Programme Manager. Dr. Harris then moved to the US for a program managerial position at Molecular Dynamics in Sunnyvale. In 1997 this company was acquired by Amersham and, over the next 4 years he was promoted to the position of Vice President of R&D for Genomics in North America. After leaving Amersham, Dr. Harris held positions of Senior VP at Aclara Biosciences, Executive VP at Vitra Bioscience, and VP of Global R&D, Business Development, and CSO at Serologicals Corporation. In July of 2006, with the acquisition of Serologicals by Millipore Corporation, Dr. Harris was promoted to his current position as VP and CSO at Millipore. |
|
| |
| |
|
| |
|
|
 |
All content copyright Biolog, Inc. © 2007. All trademarks and registered trademarks are the property of their respective companies. Use of this web site indicates that you accept the Terms and Conditions. Please see our User Privacy policy. If you have any questions or comments about Biolog's web site please contact us at info@biolog.com.
|
|
|
|
|
|
